Bicara Therapeutics Inc. Common Stock (BCAX) Institutional Ownership

Based on Q1 2026 13F filings, institutional ownership of Bicara Therapeutics Inc. Common Stock stands at 103.6%, held across 145 reporting institutions.

RA CAPITAL MANAGEMENT, L.P. is the largest reported institutional holder of BCAX, with approximately 7,255,993 shares worth $0.14B as of Q1 2026.

Yes — 1 widely-followed marquee investor appear among the top 25 institutional holders of BCAX, including CITADEL ADVISORS LLC.

Our composite Smart Money Score for BCAX is 61 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

32 institutions opened new positions in BCAX during Q1 2026, while 25 fully exited. 99 added to existing positions and 14 trimmed.

BCAX institutional ownership rose by 29.96 percentage points quarter-over-quarter, with a net change of +7 holders.

The top 10 institutions account for 64.0% of all reported 13F value in BCAX, and the top 25 account for 88.8%.

All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.